1WYATT H R.The prevalence of obesity[J].Prim Care,2003,30:267-279.
2LEUNG P S,CHAPPELL M C.A local pancreatic rennin angiotensin system:endocrine and exocrine roles[J].Int J Biochem Cell Biol,2003,35:838-846.
3FINK A S,WANG Y,MENDENZ T,et al.Angiotension Ⅱ eyokes calcium-mediated signaling events in isolated dog pancreatic epithelial cells[J].Pancreas,2002,25:290 -295.
4YUSUF S,SLEIGHT P,POGUE J,et al.The Heart Outcomes Prevention Evaluation Study,effects of an angiotensin-convertion enzyme inhibitor ramipril on cardiovascular events in high-risk patients[J].N Engl J Med,2000,342:145 -153.
5DEVEREUX R B,DAHLOF B,KJELDSEN S E,et al.Effects of losartan or atenolol in hyperensive patients without clinically evident vascular disease:a substudy of the LIFE randomized trial[J].Ann Intern Med,2003,139:169-177.
6LUCIUS R,GALLINAT S,BUSCHE S,et al.Beyond blood pressure:new roles for angiotensin Ⅱ[J].Cell Mol Life Sci,1999,56:1 008-1 019.
7BOSCH J,YUSUF S,GERSTEIN H C,et al.Effect of ramipril on the incidence of diabetes[J].N Engl J Med JT,2006,355:1 551-1 562.
8GALLINAT S,BUSCHE S,RAIZADA M K.The angiotensin Ⅱ type 2 receptor:an enigma with multiple variations[J].Am J Physiol Endocrinol Metab,2000,278:357 -374.
9NORWOOD V F,CRAIG M R,HARRIS J M,et al.Differential expression of angioteusin Ⅱ receptors during early renal morphogenesis[J].Am J Physiol,1997,272:662 -668.
10LEUNG P S,CARLSSON P O.Tissue rennin-angiotensin system:its expression,localization,regulation and potential role in the pancreas[J].J Mol Edocrinol,2001,26:155 -164.
二级参考文献12
1Leung PS, Chappell MC. A local pancreatic renin-angiotensin system:endocrine and exocrine roles. Int J Biochem Cell Biol, 2003,35:838-846.
2Tahmasebi M, Puddefoot JR, Inwang ER, et al. The tissue rennin-angiotensin system in human pancreas. J Endocrinol, 1999,161:317-322.
3Lakey JR, Kneteman NM, Rajotte RV, et al. Effect of core pancreastemperature during cadavefic procurement on human islet isolation andfunctional viability. Transplantation, 2002,73 : 1106-1110.
4Carlsson PO, Benle C, Jansson L.Angiotensin 11 and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats.Diabetologia, 1998,41 : 127-133.
5de Gasparo M, catt KJ, Inagami T, et al. International Union ofPharmacology. ⅩⅩⅠⅡ. The angiotensin Ⅱ receptors. Pharmaeol Rev,2000.52:415-472.
6Lam KY, Leung PS. Regulation and expression of a renin-angiotensin system in human pancreas and pancreatic endocrine tumours. Eur J Endocrinol. 2002.146:567-572.
7Lau T, Carlsson PO,Leung PS. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin Ⅱ in isolated pancreatic islets.Diabetologia, 2004,47:240-248.
8Nakayama M, Inoguchi T, Sonta T, et al. Increased expression of NAD (P) H oxidase in islets of animal models of type 2 diabetes and its improvement by an AT1 receptor antagonist. Biochem Biophys Res Commun, 2005,332:927-933.
9Suzuki Y, Ruiz-Ortega M, Lorenzo O, et al. Inflammation and angiotensin Ⅱ. Int J Biochem Cell Biol, 2003,35:881-900.
10Jandeleit-Dahm KA, Tikellis C, Reid CM, et al. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens, 2005.23:463-473.
